Ingenia Therapeutics

About:

Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate for capillary diseases.

Website: https://ingeniatherapeutics.com

Description:

Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate to treat multiple diseases, including cancer and inflammatory diseases. It specializes in developing antibodies for patients suffering from defective micro-vessel and progressive chronic diseases.

Total Funding Amount:

$16.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)ingeniatx.com

Founders:

Sangyeul Han

Number of Employees:

1-10

Last Funding Date:

2024-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai